Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to evaluate the clinical efficacy
of a single dose of NNC0142-0002 administered to subjects with active rheumatoid arthritis
(RA).